A new World Health Organization (WHO) study published today identifies 17 priority pathogens for vaccine development, signifying the first global effort to gauge pathogens by regional disease burden, antimicrobial resistance risk, and socioeconomic impact.
The list includes longstanding priorities for vaccine research and development, including HIV, malaria, and tuberculosis (TB), conditions that lead to 2.5 million deaths each year. The team published its findings in eBioMedicine.
The report also spotlights pathogens such as group A Streptococcus and Klebsiella pneumoniae as disease-control priorities for all regions, pointing to the urgency of the need to develop new vaccines for pathogens that are increasingly resistant to antimicrobials.
Targets for reducing disease burden and medical costs
In a WHO press release, Kate O'Brien, MD, who directs the group immunization, vaccines, and biologicals department, said global decisions on vaccine are usually driven only by return on investment, rather than the number of lives that could be saved in vulnerable communities. "This study uses broad regional expertise and data to assess vaccines that would not only significantly reduce diseases that greatly impact communities today but also reduce the medical costs that families and health systems face," she said.
This study uses broad regional expertise and data to assess vaccines that would not only significantly reduce diseases that greatly impact communities today but also reduce the medical costs.
Experts identified the top 10 priority pathogens for each region, then condensed the results down into a global list, which is separated by stage of vaccine development. Several have vaccines that are in earlier stages of development or are nearing regulatory approval or policy recommendations. The group, however, identified four that require research: group A Strep, hepatitis C, HIV-1, and K peumoniae.
The WHO said the newly released endemic priority pathogens list complements its research and development blueprint for epidemics, which identifies those that could spark future epidemics or pandemics.